Sage Therapeutics to Host Sage FutureCast Webcast

Rhea-AI Summary

Sage Therapeutics, Inc. (NASDAQ: SAGE) has announced it will host the Sage FutureCast: An R&D and Portfolio Review on December 14, from 8:00 a.m. to 10:00 a.m. ET. The event will outline the company's research and development strategies, focusing on progress in its depression, neurology, and neuropsychiatry programs, including zuranolone, SAGE-324, and SAGE-718. A live webcast will be available on Sage's investor site, with a replay accessible for up to 30 days post-event.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that it will host Sage FutureCast: An R&D and Portfolio Review on Tuesday, December 14 from 8:00 a.m. to 10:00 a.m. ET.

Sage FutureCast will discuss the Company’s research and development strategy, and clinical progress in programs throughout the depression, neurology, and neuropsychiatry franchises including zuranolone, SAGE-324 and SAGE-718, respectively.

Webcast Information
A live webcast of the presentation can be accessed on the investor page of Sage's website at investor.sagerx.com.
A replay of the webcast will be available on Sage's website approximately two hours after the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health, and our depression, neurology and neuropsychiatry franchise programs aim to change how brain disorders are thought about and treated. Our mission is to make medicines that matter so people can get better, sooner. For more information, please visit www.sagerx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211129005132/en/

Investor Contact

Helen Rubinstein

315-382-3979

helen.rubinstein@sagerx.com

Media Contact

Maureen L. Suda

617-949-4289

maureen.suda@sagerx.com

Source: Sage Therapeutics, Inc.

FAQ

What is the date and time of the Sage FutureCast event?

The Sage FutureCast event is scheduled for December 14, from 8:00 a.m. to 10:00 a.m. ET.

Where can I watch the Sage FutureCast webcast?

You can watch the Sage FutureCast webcast on the investor page of Sage Therapeutics' website.

What topics will be covered during the Sage FutureCast event?

The event will cover Sage's R&D strategy and clinical progress in depression, neurology, and neuropsychiatry programs.

What key programs will Sage discuss at the FutureCast?

Sage will discuss key programs including zuranolone, SAGE-324, and SAGE-718.

Will there be a replay available for the Sage FutureCast?

Yes, a replay of the Sage FutureCast will be available approximately two hours after the event and archived for up to 30 days.